139 related articles for article (PubMed ID: 9414014)
1. Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex.
Jentsch JD; Wise A; Katz Z; Roth RH
Synapse; 1998 Jan; 28(1):21-6. PubMed ID: 9414014
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the phencyclidine-induced increase in prefrontal cortical dopamine metabolism in the rat.
Umino A; Takahashi K; Nishikawa T
Br J Pharmacol; 1998 May; 124(2):377-85. PubMed ID: 9641556
[TBL] [Abstract][Full Text] [Related]
3. Clonidine and guanfacine attenuate phencyclidine-induced dopamine overflow in rat prefrontal cortex: mediating influence of the alpha-2A adrenoceptor subtype.
Jentsch JD; Sanchez D; Elsworth JD; Roth RH
Brain Res; 2008 Dec; 1246():41-6. PubMed ID: 18977208
[TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an alpha-1 noradrenergic antagonist.
Bakshi VP; Geyer MA
J Pharmacol Exp Ther; 1997 Nov; 283(2):666-74. PubMed ID: 9353384
[TBL] [Abstract][Full Text] [Related]
5. Noradrenergic modulation of cognitive function in rat medial prefrontal cortex as measured by attentional set shifting capability.
Lapiz MD; Morilak DA
Neuroscience; 2006 Feb; 137(3):1039-49. PubMed ID: 16298081
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical interaction between dopaminergic and noradrenergic neurons in the medial prefrontal cortex.
Pan WH; Yang SY; Lin SK
Synapse; 2004 Jul; 53(1):44-52. PubMed ID: 15150740
[TBL] [Abstract][Full Text] [Related]
7. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
8. Mirtazapine-induced corelease of dopamine and noradrenaline from noradrenergic neurons in the medial prefrontal and occipital cortex.
Devoto P; Flore G; Pira L; Longu G; Gessa GL
Eur J Pharmacol; 2004 Mar; 487(1-3):105-11. PubMed ID: 15033381
[TBL] [Abstract][Full Text] [Related]
9. Noradrenergic alpha-2 agonists have anxiolytic-like actions on stress-related behavior and mesoprefrontal dopamine biochemistry.
Morrow BA; George TP; Roth RH
Brain Res; 2004 Nov; 1027(1-2):173-8. PubMed ID: 15494168
[TBL] [Abstract][Full Text] [Related]
10. Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine.
Shi WX; Zhang XX
J Pharmacol Exp Ther; 2003 May; 305(2):680-7. PubMed ID: 12606677
[TBL] [Abstract][Full Text] [Related]
11. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of haloperidol on phencyclidine-induced reduction in substance P contents in rat brain regions.
Shirayama Y; Mitsushio H; Takahashi K; Nishikawa T
Synapse; 2000 Mar; 35(4):292-9. PubMed ID: 10657039
[TBL] [Abstract][Full Text] [Related]
13. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
14. Effects of corticotropin-releasing hormone receptor antagonists on cocaine-induced dopamine overflow in the medial prefrontal cortex and nucleus accumbens of rats.
Gurkovskaya OV; Palamarchouk V; Smagin G; Goeders NE
Synapse; 2005 Sep; 57(4):202-12. PubMed ID: 15986362
[TBL] [Abstract][Full Text] [Related]
15. Activation of medial prefrontal cortex neurons by phencyclidine is mediated via AMPA/kainate glutamate receptors in anesthetized rats.
Katayama T; Jodo E; Suzuki Y; Hoshino KY; Takeuchi S; Kayama Y
Neuroscience; 2007 Dec; 150(2):442-8. PubMed ID: 17935894
[TBL] [Abstract][Full Text] [Related]
16. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence.
Jentsch JD; Tran A; Taylor JR; Roth RH
Psychopharmacology (Berl); 1998 Jul; 138(1):89-95. PubMed ID: 9694531
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with Delta-9-tetrahydrocannabinol alters the structure of neurons in the nucleus accumbens shell and medial prefrontal cortex of rats.
Kolb B; Gorny G; Limebeer CL; Parker LA
Synapse; 2006 Nov; 60(6):429-36. PubMed ID: 16881072
[TBL] [Abstract][Full Text] [Related]
19. Autoreceptor-mediated inhibition of norepinephrine release in rat medial prefrontal cortex is maintained after chronic desipramine treatment.
Garcia AS; Barrera G; Burke TF; Ma S; Hensler JG; Morilak DA
J Neurochem; 2004 Nov; 91(3):683-93. PubMed ID: 15485498
[TBL] [Abstract][Full Text] [Related]
20. Clozapine, but not haloperidol, prevents the functional hyperactivity of N-methyl-D-aspartate receptors in rat cortical neurons induced by subchronic administration of phencyclidine.
Arvanov VL; Wang RY
J Pharmacol Exp Ther; 1999 May; 289(2):1000-6. PubMed ID: 10215680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]